Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Gaurav Pande"'
Autor:
Pritam Das, Rakesh S. Kumar, Swapnil Mujawdiya, Dhruv Thakur, Nagnath Wodeyar, Kartik Balankhe, Vivek Anand Saraswat, Gaurav Pande, Samir Mohindra
Publikováno v:
Journal of Digestive Endoscopy, Vol 15, Iss 01, Pp 35-41 (2024)
Background Pancreaticopleural fistula (PPF) is a rare complication associated with pancreatitis, caused by disruption of the pancreatic duct, either directly or through rupture of a peripancreatic fluid collection, resulting in leakage of pancreatic
Externí odkaz:
https://doaj.org/article/ef5df82aa601438c93a2143e716e027a
Autor:
Ritu Raj, Nipanshu Agarwal, Sriram Raghavan, Tapati Chakraborti, Krishna Mohan Poluri, Gaurav Pande, Dinesh Kumar
Publikováno v:
ACS Omega, Vol 6, Iss 5, Pp 3548-3570 (2021)
Externí odkaz:
https://doaj.org/article/53d15e3f9a4545d68db9f01a38f3dc9f
Autor:
Umesh Kumar, Supriya Sharma, Manjunath Durgappa, Nikhil Gupta, Ritu Raj, Alok Kumar, Prabhat N Sharma, V P Krishna, R Venkatesh Kumar, Anupam Guleria, Vivek A Saraswat, Gaurav Pande, Dinesh Kumar
Publikováno v:
Journal of Pharmacy and Bioallied Sciences, Vol 13, Iss 2, Pp 276-282 (2021)
Objectives: Acute-on-chronic liver failure (ACLF), which develops in patients with underlying alcoholic liver disease (ALD), is characterized by acute deterioration of liver function and organ failures are secondary to that. The clear understanding o
Externí odkaz:
https://doaj.org/article/03ecdbdf2d084f4d8a4572d7a80ad8c8
Publikováno v:
Indian Journal of Rheumatology, Vol 16, Iss 3, Pp 298-303 (2021)
Despite availability of commercially available cell lines, primary cultures of cells remain the best available natural resource for in vitro research work. However, establishing primary cultures is challenging and despite availability of many protoco
Externí odkaz:
https://doaj.org/article/6387a8bd94c045938be0011290227ae7
Autor:
Hemanta K. Nayak, Sandeep Kumar, Uday C. Ghoshal, Samir Mohindra, Namita Mohindra, Gaurav Pande, Vivek Anand Saraswat
Publikováno v:
Journal of Digestive Endoscopy, Vol 08, Iss 02, Pp 061-067 (2017)
Background: We evaluated short‑ and long‑term results of endoscopic drainage (a minimally invasive nonsurgical treatment) of pancreatic pseudocysts (PPCs) and factors associated with its success at a multilevel teaching hospital in Northern India
Externí odkaz:
https://doaj.org/article/242a1375585543f1a098ab99f5f41a97
Autor:
Gaurav Pande, Manjunath Hatti, Mohit Kumar Rai, Praveer Rai, Kamlesh Kumar, Krishna VP, Abhimanyu Nehra, Sudeep Kumar, Smarak Ranjan Rout, Sourav Kumar Mishra, Dinesh Kumar, Umesh Kumar, Prabhaker Mishra, Abdul Majeed, Vivek Anand Saraswat, Kritika Singh, Harshit Singh, Durga Prasanna Misra, Vikas Agarwal
Publikováno v:
Journal of Inflammation Research. 15:5027-5039
Gaurav Pande,1 Manjunath Hatti,1 Mohit Kumar Rai,2 Praveer Rai,1 Kamlesh Kumar,1 Krishna VP,1 Abhimanyu Nehra,1 Sudeep Kumar,3 Smarak Ranjan Rout,3 Sourav Kumar Mishra,3 Dinesh Kumar,4 Umesh Kumar,4 Prabhaker Mishra,5 Abdul Majeed,1 Vivek Anand Saras
Publikováno v:
J Clin Exp Hepatol
BACKGROUND AND AIMS: Erectile dysfunction (ED) is common in patients with compensated cirrhosis but its impact on the quality of life (QOL) is usually overlooked. This study aimed at determining the frequency of ED in male patients with compensated c
Publikováno v:
npj Systems Biology and Applications, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Interactions between protein kinases and their substrates are critical for the modulation of complex signaling pathways. Currently, there is a large amount of information available about kinases and their substrates in disparate public datab
Externí odkaz:
https://doaj.org/article/69df9506969843f9bc1b4a7304e8e93d
Autor:
Supriya Sharma, Umesh Kumar, Gaurav Pande, Ritu Raj, Anupam Guleria, Payal Arya, Dinesh Kumar, Manjunath Durgappa
Publikováno v:
Analytical Science Advances. 2:536-545
Publikováno v:
Clinical rheumatologyReferences.
Considerable controversy related to the cardiovascular safety of Janus kinase inhibitors (JAKinibs) has arisen following the results of the ORAL Surveillance trial. In this trial of rheumatoid arthritis (RA) ≥ 50 years with at least one prevalent c